The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Add‐back therapy with GnRH analogues for uterine fibroids
|
|---|---|
| Published in |
Cochrane database of systematic reviews, March 2015
|
| DOI | 10.1002/14651858.cd010854.pub2 |
| Pubmed ID | |
| Authors |
Rafael M Moroni, Wellington P Martins, Rui A Ferriani, Carolina S Vieira, Carolina O Nastri, Francisco José Candido Dos Reis, Luiz Gustavo Brito |
| Abstract |
Uterine fibroids (also known as leiomyomas) are the most common benign pelvic tumours among women. They may be asymptomatic, or may be associated with pelvic symptoms such as bleeding and pain. Medical treatment of this condition is limited and gonadotropin-releasing hormone (GnRH) analogues are the most effective agents. Long-term treatment with such agents, however, is restricted due to their adverse effects. The addition of other medications during treatment with GnRH analogues, a strategy known as add-back therapy, may limit these side effects. There is concern, however, that add-back therapy may also limit the efficacy of the GnRH analogues and that it may not be able to completely prevent their adverse effects. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 50% |
| Unknown | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 201 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 199 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 30 | 15% |
| Student > Bachelor | 26 | 13% |
| Other | 18 | 9% |
| Researcher | 14 | 7% |
| Student > Postgraduate | 13 | 6% |
| Other | 31 | 15% |
| Unknown | 69 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 73 | 36% |
| Nursing and Health Professions | 20 | 10% |
| Psychology | 7 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 3% |
| Social Sciences | 5 | 2% |
| Other | 19 | 9% |
| Unknown | 70 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 July 2019.
All research outputs
#15,853,376
of 26,370,291 outputs
Outputs from Cochrane database of systematic reviews
#10,985
of 13,211 outputs
Outputs of similar age
#142,287
of 278,547 outputs
Outputs of similar age from Cochrane database of systematic reviews
#218
of 269 outputs
Altmetric has tracked 26,370,291 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,211 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.7. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 278,547 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 269 others from the same source and published within six weeks on either side of this one. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.